Spectrum Library

Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge

Publication Date April 2020

Neuromyelitis optica spectrum disorder Patient experience and quality of life

Publication Date July 2019

Optic neuritis at disease onset predicts poor visual outcome in neuromyelitis optica spectrum disorders

Publication Date March 2020

Neuromyelitis optica spectrum disorders in Arabian Gulf (NMOAG); establishment and initial characterization of a patient registry

Publication Date October 2019

The history of neuromyelitis optica. Part 2: ‘Spinal amaurosis’, or how it all began.

Publication Date December 2019

Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus.

Publication Date August 2019

Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques

Publication Date September 2019

Early B cell tolerance defects in NMO favour anti-AQP4 autoantibody production

Publication Date June 2019

Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial.

Publication Date April 2019

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders.

Publication Date April 2019

Rituximab in neurological disease: principles, evidence and practice.

Publication Date November 2018

MOG-IgG-associated disease has a stereotypical clinical course, asymptomatic visual impairment and good treatment response

Publication Date July 2018

Previous
1
2
3
4
5
…
78
Next

Launch Dashboard